Alliance Discussion with Andi Fristedt, FDA

What are FDA’s 2023 priorities under the new drug and medical device user fee bills? What exactly was included about clinical trial diversity in December’s Omnibus legislation? On Wednesday, February 15 at 1pm ET, join our conversation with FDA Deputy Commissioner for Policy, Legislation and International Affairs, Andi Fristedt, for an inside look at key issues impacting patients, researchers and industry.